CIK: 1445826 - Address: C/O Tempus Ai, Inc., 600 West Chicago Avenue, Suite 510, Chicago, IL 60654
11 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
9/4/25 16:15
9/2/25
TEMTempus Ai, Inc.NVTechSoftwComputer Programming, Data PrEpstein David RILDS-1873.6400-127D
8/5/25 16:15
8/1/25
TEMTempus Ai, Inc.DETechSoftwComputer Programming, Data PrEpstein David RILDS-2055.1600-127D
6/4/25 16:15
6/2/25
TEMTempus Ai, Inc.DETechSoftwComputer Programming, Data PrEpstein David RILDS-1455.2000-128D
5/5/25 16:15
5/1/25
TEMTempus Ai, Inc.DETechSoftwComputer Programming, Data PrEpstein David RILDS-2053.5000-126D
3/19/25 18:30
3/17/25
TEMTempus Ai, Inc.DETechSoftwComputer Programming, Data PrEpstein David RILDS-4646.830-1-426D
3/5/25 16:15
3/3/25
TEMTempus Ai, Inc.DETechSoftwComputer Programming, Data PrEpstein David RILDS-1457.5200-127D
2/5/25 18:06
2/3/25
TEMTempus Ai, Inc.DETechSoftwComputer Programming, Data PrEpstein David RILDS-2053.3100-128D
12/13/24 18:20
12/11/24
TEMTempus Ai, Inc.DETechSoftwComputer Programming, Data PrEpstein David RILDS-2641.810-1-228D
11/13/23 20:02
11/10/23
SGENSeagen Inc.WAHealthBioPrdBiological Products, (No DiagEpstein David RWADOCEOS-2,262213.010-11-7137D
2/16/21 21:51
2/11/21
RUBYRubius Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagEpstein David RMADS-39914.930-27-14,690D
2/10/21 21:12
2/8/21
RUBYRubius Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagEpstein David RMADS.m-1,46914.880-99-24,717D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact